About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 321 record(s)
Req # A-2020-001110
Adverse Drug Reactions (ADRs). Report numbers: E2B_02041977, E2B_02043108, E2B_02044808, E2B_02045328, E2B_02046655, E2B_02046963, E2B_02048892, E2B_02051810, E2B_02052231, E2B_02053927, E2B_02055819, E2B_02056812, E2B_02057812, E2B_02059789, E2B_02059934, E2B_02060977, E2B_02063123, E2B_02067212, E2B_02067623, E2B_02071689.Organization: Health Canada
March 2022
Req # A-2020-001159
Adverse Drug Reactions (ADRs). Report numbers: E2B_02344531, E2B_02344983, E2B_02347713, E2B_02347714, E2B_02347769, E2B_02348437, E2B_02348523, E2B_02349612, E2B_02349617, E2B_02350000, E2B_02352161, E2B_02352907, E2B_02352926, E2B_02353284, E2B_02353302, E2B_02354445, E2B_02354974, E2B_02355147, E2B_02355537, E2B_02356711.Organization: Health Canada
March 2022
Req # A-2020-001177
Adverse Drug Reactions (ADRs). Report numbers: E2B_02389671, E2B_02390007, E2B_02390411, E2B_02391388, E2B_02392231, E2B_02393515, E2B_02393557, E2B_02394142, E2B_02394438, E2B_02394642, E2B_02394788, E2B_02395206, E2B_02395222, E2B_02395685, E2B_02396154, E2B_02396161, E2B_02396209, E2B_02396216, E2B_02396234, E2B_02396256.Organization: Health Canada
March 2022
Req # A-2020-001346
Adverse Drug Reactions (ADRs). Report numbers: E2B_02781679, E2B_02781681, E2B_02781691, E2B_02781694, E2B_02781703, E2B_02782262, E2B_02782720, E2B_02783224, E2B_02783264, E2B_02783825, E2B_02784757, E2B_02785476, E2B_02785648, E2B_02785695, E2B_02785816, E2B_02785821, E2B_02786190, E2B_02786230, E2B_02786964, E2B_02787470.Organization: Health Canada
March 2022
Req # A-2020-001446
Adverse Drug Reactions (ADRs) for INSULIN GLARGINE. Report numbers: 737809, 911437, 737948, E2B_03109232, E2B_03063606, 915277, 909889, E2B_03067602, E2B_03042979, 908950.Organization: Health Canada
March 2022
Req # A-2020-001448
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 916069, E2B_03076262, E2B_02992054, E2B_02992210, E2B_02995815, E2B_02997297, E2B_03025144, E2B_03001754, E2B_03007735, E2B_02997322, E2B_03000383, E2B_03000116, E2B_03007147, E2B_02997365, E2B_03000022, E2B_03002942, E2B_03026410, E2B_03024422, E2B_03076360, E2B_03069833.Organization: Health Canada
March 2022
Req # A-2020-001482
Adverse Drug Reaction (ADR) for Rifampicin. Report number: E2B_03040063.Organization: Health Canada
March 2022
Req # A-2020-001483
Adverse Drug Reaction (ADR) for Thyrotropin Alfa. Report number: E2B_03053741.Organization: Health Canada
March 2022
Req # A-2020-001513
Adverse Drug Reactions (ADRs) for ALEMTUZUMAB. Report numbers: 000914488, 000914749, 000915924, 000916620.Organization: Health Canada
March 2022
Req # A-2020-001546
Adverse Drug Reactions (ADRs). Report numbers: E2B_03157176, E2B_03157853, E2B_03158727, E2B_03158859, E2B_03160209, E2B_03160212, E2B_03160332, E2B_03161187, E2B_03161439, E2B_03162413, E2B_03165742, E2B_03166078, E2B_03166102, E2B_03166583, E2B_03166917, E2B_03168108, E2B_03168620, E2B_03168681, E2B_03170001, E2B_03170182.Organization: Health Canada
March 2022